Pursuant to Regulation 30 read with Part A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015, Gland Pharma has informed that the Analyst/ Institutional Investor Meeting with SBI Mutual Fund held on 26th December 2022 in the form of in-person, One on One meeting. The schedule of the above-mentioned meeting is subject to change and the change may occur due to exigencies on the part of the Investor/ Analyst/ Company.
The above information is a part of company’s filings submitted to BSE.
